Insiders / Balthaser Kevin / Activity
Activity — Balthaser Kevin
20 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Dec 31, 2025 | Other | ACRS Aclaris Therapeutics, Inc. Common Stock | $60.0K | -20K -11.98% | 146,424 0.10% of shares | low |
| Feb 3, 2026 | Other | ACRS Aclaris Therapeutics, Inc. Common Stock | $22.4K | -6K -3.36% | 185,755 0.13% of shares | low |
| Feb 1, 2026 | Other | ACRS Aclaris Therapeutics, Inc. Common Stock | $17.5K | -5K -2.85% | 170,179 0.12% of shares | low |
| Jan 2, 2026 | Other | ACRS Aclaris Therapeutics, Inc. Common Stock | $12.8K | -4K -2.71% | 160,413 0.11% of shares | low |
| Jan 1, 2026 | Other | ACRS Aclaris Therapeutics, Inc. Common Stock | $6.8K | -2K -1.46% | 151,674 0.10% of shares | low |
| Mar 1, 2026 | Other | ACRS Aclaris Therapeutics, Inc. Common Stock | $1.9K | -677 -0.36% | 187,453 0.13% of shares | low |
| Mar 1, 2026 | Exercise | ACRS Aclaris Therapeutics, Inc. Restricted Stock Units | — | -2K -100.00% | 0 0.00% of shares | low |
| Mar 1, 2026 | Exercise | ACRS Aclaris Therapeutics, Inc. Common Stock | — | +2K +1.28% | 188,130 0.13% of shares | low |
| Feb 2, 2026 | Grant | ACRS Aclaris Therapeutics, Inc. Employee Stock Option (Right to Buy) | — | +347K | 346,800 0.24% of shares | low |
| Feb 2, 2026 | Grant | ACRS Aclaris Therapeutics, Inc. Restricted Stock Units | — | +99K | 99,100 0.07% of shares | low |
| Feb 3, 2026 | Exercise | ACRS Aclaris Therapeutics, Inc. Restricted Stock Units | — | -22K -25.00% | 66,075 0.04% of shares | low |
| Feb 3, 2026 | Exercise | ACRS Aclaris Therapeutics, Inc. Common Stock | — | +22K +12.94% | 192,204 0.13% of shares | low |
| Feb 1, 2026 | Exercise | ACRS Aclaris Therapeutics, Inc. Restricted Stock Units | — | -15K -33.33% | 29,500 0.02% of shares | low |
| Feb 1, 2026 | Exercise | ACRS Aclaris Therapeutics, Inc. Common Stock | — | +15K +9.20% | 175,163 0.12% of shares | low |
| Jan 2, 2026 | Exercise | ACRS Aclaris Therapeutics, Inc. Restricted Stock Units | — | -13K -49.25% | 13,600 <0.01% of shares | low |
| Jan 1, 2026 | Exercise | ACRS Aclaris Therapeutics, Inc. Restricted Stock Units | — | -8K -50.00% | 7,500 <0.01% of shares | low |
| Dec 31, 2025 | Exercise | ACRS Aclaris Therapeutics, Inc. Restricted Stock Units | — | -74K -100.00% | 0 0.00% of shares | low |
| Jan 2, 2026 | Exercise | ACRS Aclaris Therapeutics, Inc. Common Stock | — | +13K +8.70% | 164,874 0.11% of shares | low |
| Jan 1, 2026 | Exercise | ACRS Aclaris Therapeutics, Inc. Common Stock | — | +8K +5.12% | 153,924 0.10% of shares | low |
| Dec 31, 2025 | Exercise | ACRS Aclaris Therapeutics, Inc. Common Stock | — | +74K +79.64% | 166,358 0.11% of shares | low |